Anixa Biosciences Inc
Anixa Biosciences Inc (ANIX): 10 pipeline candidates · ~23 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
23.1 months
D/E 0.11 · 0% dilution
Lead: Phase 1
10 candidates
N/A
1 buy · 0 sells (180d)
A transparent, data-derived signal for Anixa Biosciences Incacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$88.5M
Cash
$1.5M
Quarterly Burn
$1.7M
Runway
23.1 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (10 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
61
Total value held
$13.6M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 2,629,964 | $6.8M |
| d.a. davidson & co. | 539,272 | $1.4M |
| geode capital management, llc | 364,731 | $941K |
| vanguard fiduciary trust co | 191,074 | $493K |
| marshall wace, llp | 173,179 | $447K |
| blackrock, inc. | 170,103 | $439K |
| state street corp | 159,040 | $410K |
| susquehanna international group, llp | 133,668 | $345K |
| lpl financial llc | 80,976 | $209K |
| northern trust corp | 66,825 | $172K |
Showing top 10 of 61 institutional holders of Anixa Biosciences Inc. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Anixa Biosciences Inc's pipeline?
Anixa Biosciences Inc (ANIX) has 10 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Anixa Biosciences Inc's lead drug candidate?
Anixa Biosciences Inc's most advanced tracked candidate is alpha-lactalbumin breast cancer vaccine (Phase 1) for Preventative vaccine against triple negative breast cancer (TNBC) and other breast cancers that express alpha-lactalbumin.
What is Anixa Biosciences Inc's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Anixa Biosciences Inc has approximately 23.1 months of cash runway.
What is Anixa Biosciences Inc's market capitalization?
Anixa Biosciences Inc's market capitalization is approximately $88.5M.
Who is the CEO of Anixa Biosciences Inc?
Dr. Amit Kumar Ph.D. is the chief executive officer of Anixa Biosciences Inc (ANIX).
Get the full picture on Anixa Biosciences Inc
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.